España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Rite Aid
RADCQ
OTCEM
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.020000
0
0.00%
Last update: 1:22 PM
15 minutes delayed
Get Report
Comment
Rite Aid (RADCQ) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Rite Aid (OTC:RADCQ) Stock
Rite Aid Stock (OTC: RADCQ)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 01, 2024
CVS, Rite Aid, Walgreens Hit Hard By Online Pharmacy Trend
Vandana Singh
Thursday, June 27, 2024
Walgreens Plans 'Significant' Store Closures As It Faces 'Difficult Operating Environment'
Michael Juliano
Tuesday, June 25, 2024
Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute
Vandana Singh
Wednesday, June 12, 2024
Rite Aid, Instacart Expand Partnership To Off...
Benzinga Newsdesk
Wednesday, March 27, 2024
Rite Aid Forges Path To Financial Recovery With Major Settlement: Report
Shivani Kumaresan
Wednesday, December 13, 2023
Privacy Risks Flagged: Major Pharmacy Chains Share Customer Data With Authorities Without Warrant
Vandana Singh
Friday, November 17, 2023
Drugstore Chain Rite Aid Counters DOJ Lawsuit Amid Bankruptcy, Aiming To Safeguard Restructuring
Vandana Singh
Wednesday, November 15, 2023
Could Your Eye Drops Be Unsafe? FDA Flags Amazon For Distributing Risky Eye Products, Demands Immediate Action
Nabaparna Bhattacharya
Monday, October 30, 2023
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
Vandana Singh
'Pharmageddon' - Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report
Shivani Kumaresan
Risk of Eye Infection - FDA Issues Strong Warning on Eye Drops from Major Retailers
Vandana Singh
Saturday, October 28, 2023
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
Nabaparna Bhattacharya
Thursday, October 19, 2023
Walgreens Agrees To Pay $192.5M To Resolve Rite Aid Buyout Suit: Report
Shivani Kumaresan
Tuesday, October 17, 2023
Rite Aid Receives Court Approval Of "First Da...
Benzinga Newsdesk
